Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study)

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1433-2965
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Efficacy and safety of once-yearly zoledronic acid in Japanese patients with primary osteoporosis: two-year results from a randomized placebo-controlled double-blind study (ZOledroNate treatment in Efficacy to osteoporosis; ZONE study) ; day:8 ; month:9 ; year:2016 ; pages:1-10
Osteoporosis international ; (8.9.2016), 1-10

Creator
Nakamura, T.
Contributor
Fukunaga, M.
Nakano, T.
Kishimoto, H.
Ito, M.
Hagino, H.
Sone, T.
Taguchi, A.
Tanaka, S.
Ohashi, M.
Ota, Y.
Shiraki, M.
SpringerLink (Online service)

DOI
10.1007/s00198-016-3736-y
URN
urn:nbn:de:1111-2016100621147
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Nakamura, T.
  • Fukunaga, M.
  • Nakano, T.
  • Kishimoto, H.
  • Ito, M.
  • Hagino, H.
  • Sone, T.
  • Taguchi, A.
  • Tanaka, S.
  • Ohashi, M.
  • Ota, Y.
  • Shiraki, M.
  • SpringerLink (Online service)

Other Objects (12)

Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study

Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study

Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes

Efficacy of Osteoporosis Medications in Patients with Type 2 Diabetes

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis

Hepatotoxicity induced by zoledronic acid in an aged woman with primary osteoporosis

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study

Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective study

Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study

Efficacy of Yigu® versus Aclasta® in Chinese postmenopausal women with osteoporosis: a multicenter prospective study

Osteoporosis

Osteoporosis

Efficacy of a workplace osteoporosis prevention intervention: a cluster randomized trial

Efficacy of a workplace osteoporosis prevention intervention: a cluster randomized trial

The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study

The effectiveness of intravenous zoledronic acid in elderly patients with osteoporosis after rotator cuff repair: a retrospective study

Depression and Osteoporosis: A Mendelian Randomization Study

Depression and Osteoporosis: A Mendelian Randomization Study

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia

Effect of zoledronic acid on muscle metabolism in mice with osteoporosis combined with sarcopenia

Related objects